.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
710 Labs is stocked at 766 licensed dispensaries across California, Michigan, and 5 other states, 309 of them in California, with the deepest coverage in Los Angeles, San Diego, San Francisco, San Jose, and Santa Ana. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, 710 Labs concentrated its volume into three pillars: Concentrates at 38.20% share with 14.22% YoY growth and 1.78% MoM, Flower at 29.48% share with 84.11% YoY and 5.61% MoM, and Vapor Pens at 22.54% share with 32.21% YoY and 9.32% MoM; Pre-Roll added 9.77% share with 75.63% YoY and 8.07% MoM while Edible collapsed to 0.01% share with -99.05% YoY and -84.78% MoM. Despite a -5.69% YoY decline in average price to $33.02 and Concentrates average price at $47.06, category breadth widened through rapid gains in Flower and Pre-Roll while maintaining a top concentration in Concentrates; the pattern implies a balanced portfolio shift where growth is diversifying beyond extracts without eroding the core.
The mix suggests 710 Labs is repositioning toward a dual-engine model: legacy Concentrates volume remains the largest at 38.20% share with only 1.78% MoM, while newer growth vectors in Flower at 29.48% share with 84.11% YoY and Vapor Pens at 22.54% share with 32.21% YoY accelerate unit acquisition alongside an 8.07% MoM push in Pre-Roll. With rank 2 in Concentrates in Colorado and category shares tilting toward inhalables, the declining Edible presence at -99.05% YoY signals a deliberate focus on high-velocity inhalable formats; the implication is sustained premium positioning in extracts paired with scale-seeking moves in Flower and Pens to stabilize seasonality and broaden shopper reach.
Competitive Landscape
710 Labs ranks #3 in CA Concentrates in October 2026, unchanged from #3 year over year, after slipping from a peak of #2 in September 2026 and down one position from #2 three months ago; by contrast, Raw Garden held #1 with a 10.9% YoY sales increase while STIIIZY stayed at #2 with 20.1% YoY growth, and Hashish advanced to #5 from #9 YoY on 82.7% growth, indicating that flat rank at #3 amid faster-moving rivals suggests stability but also rising competitive pressure for share retention.
Notable Products
In October 2026, 710 Labs's best seller, Premium Lemon Heads #4 Live Rosin Disposable (1g), brought in 1.3% of its sales, and its top 10 products brought in 9.8%. Products first sold in the last six months made up 13.9% of sales. Its prices ran 58.0% above the average for the same product type and pack size in the same states.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
